BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Maryland Psychiatric Society - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mdpsych.org
X-WR-CALDESC:Events for Maryland Psychiatric Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171111T083000
DTEND;TZID=America/New_York:20171111T143000
DTSTAMP:20170907T154515Z
CREATED:20170904T182725Z
LAST-MODIFIED:20170907T154515Z
UID:2276-1510389000-1510410600@mdpsych.org
SUMMARY:Psychopharmacology Update: 2017
DESCRIPTION: Register and Pay Online!\nSaturday November 11\, 2017\n8:30 am-3:30 pm \nThe Conference Center at Sheppard Pratt\n6501 North Charles Street\nBaltimore\, MD 21204 \n  \nAbout The Program:\nMood disorders are complex conditions. They are challenging to diagnose even for experienced health care professionals. Delays in diagnosis and treatment lead to poor outcomes for patients as they suffer from effects on mental and physical health. About 30% of people report depression as one of their symptoms when they see their doctor. But fewer than 10% actually have severe depression. Nearly 4% of the U.S. population have a bipolar disorder. We are honored to welcome several national thought leaders and investigators in mood disorders to present on this topic. \n  \nAgenda: \n8:30AM Breakfast and Registration \n9:00AM The Problem of Psychiatric Diagnosis: Still a long way from biology – Scott Aaronson\, M.D. \n10:00AM Management of Mood & Anxiety Disorders in Pregnancy and Lactation – Lauren Osborne\, M.D. \n11:00AM Break \n11:15AM Recognition of Childhood Onset Bipolar Disorders – Robert Post\, M.D. \n12:15PM Lunch \n1:15PM Psychosis and Schizophrenia in Clinical Practice – David Pickar\, M.D. \n2:15PM Break \n2:30PM Neurostimulation 2017: ECT\, TMS & VNS – Scott Aaronson\, M.D. \n  \nSpeaker Information: \nScott Aaronson\, M.D. – Dr. Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry\, diagnosis and the integration of somatic and psychological therapies. He is the principal investigator for multiple studies on the development of novel therapies for mood\, anxiety and psychotic disorders. Dr. Aaronson currently serves as a Clinical Assistant Professor of Psychiatry at the University of Maryland School of Medicine and is also the Associate Medical Director and Director of Clinical Research at The Retreat at Sheppard Pratt. \nLauren Osborne\, M.D. – Dr. Osborne is the Assistant Director at Johns Hopkins Women’s Mood Disorders Center. She graduated from Weill Cornell Medical College and received her training at Columbia University/New York State Psychiatric Institute. She completed both clinical and research fellowships in women’s mental health\, and is an expert on the diagnosis and treatment of mood and anxiety disorders during pregnancy\, the postpartum\, the premenstrual period\, and perimenopause. \nRobert Post\, M.D. – Dr. Post founded the International Stanley Foundation Bipolar Network (now the Bipolar Collaborative Network). Throughout his career\, including 35 years at the NIMH\, and 20 of those as Chief of the Biological Psychiatry Branch\, Dr. Post has focused on bettering the understanding and treatment of refractory unipolar and bipolar illness. Currently\, he is in private practice and attempting to address childhood-onset bipolar illness. \nDavid Pickar\, M.D. – Dr. Pickar is Adjunct Professor of Psychiatry at Johns Hopkins University School of Medicine. He served in the Intramural Research Program (IRP) of the National Institute of Mental Health (NIMH) for over 20 years where he was the Chief of the Experimental Therapeutics Branch dedicated to studying schizophrenia and psychosis. Dr. Pickar is Founder and President of Gabriel Sciences\, a company whose mission is advancing the development of a novel treatment for schizophrenia. He practices psychiatry in Chevy Chase\, Maryland. \n  \nGoals & Objectives: \nAt the conclusion of the program\, the participant should be able to: \n\nKnow the literature on more childhood onset bipolar disorder in the US and understand the vulnerabilities and risk factor for it\nBecome aware of the progressive nature of bipolar disorder driven by epigenetic mechanisms.\nDefine risks of untreated psychiatric illness during and after pregnancy\nDefine risks and benefits of psychiatric medication during and after pregnancy\nIdentify at least two treatment alternatives for mood and anxiety disorders during and after pregnancy.\nRecognize variants in the presentation of depression and when symptoms suggest treatment is needed for bipolar disorder\nCreate the treatment paradigm for the longterm management of difficult to treat depression using neurostimulation.\nDescribe the developments seen with the introduction of new second generation antipsychotics\n\n  \nAccreditation/Designation Statements \nThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of American Psychiatric Association (APA) and Maryland Psychiatric Society (MPS). The APA is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this live activity for a maximum of 5 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nThis activity is approved for a maximum of 5 hours of Category IContinuing Education for Social Workers by the Maryland Board of Social Workers. \nThis activity is approved for a maximum of 5 hours of Continuing Education for Psychologists by the Maryland Board of Examiners for Psychologists. \n  \nFees are non-refundable.
URL:https://mdpsych.org/meetings/psychopharmacology-update/
LOCATION:Conference Center at Sheppard Pratt\, 6501 North Charles Street\, Towson\, MD\, 21204\, United States
ATTACH;FMTTYPE=image/jpeg:https://mdpsych.org/wp-content/uploads/2017/09/Untitled.jpg
ORGANIZER;CN="Maryland Psychiatric Society":MAILTO:mps@mdpsych.org
END:VEVENT
END:VCALENDAR